Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Sweden flag Sweden · Delayed Price · Currency is SEK
3.290
-0.060 (-1.79%)
At close: Mar 19, 2026
Market Cap314.18M +175.4%
Revenue (ttm)63.11M +107.0%
Net Income-15.25M
EPS-0.18
Shares Out99.42M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume124,249
Average Volume107,339
Open3.400
Previous Close3.350
Day's Range3.010 - 3.550
52-Week Range0.950 - 3.570
Beta1.04
RSI56.31
Earnings DateFeb 20, 2026

About Bio-Works Technologies AB

Bio-Works Technologies AB (publ), together with its subsidiaries, engages in the manufactures and sale of chromatography resins for the purification of biopharmaceuticals in Sweden. The company offers affinity and activated resin, hydrophobic interaction chromatography (HIC) resins, GoBio Mini and GoBio prepacked columns, ion exchange chromatography (IEX) resin, immobilized metal-ion affinity chromatography (IMAC) resin, size exclusion chromatography (SEC) resins, HTPD formats, screening kits, and desalting columns; and WorkBeads chromatography... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 26
Stock Exchange Nordic Growth Market
Ticker Symbol BIOWKS
Full Company Profile

Financial Performance

In 2025, Bio-Works Technologies AB's revenue was 63.11 million, an increase of 107.01% compared to the previous year's 30.49 million. Losses were -15.25 million, -59.19% less than in 2024.

Financial Statements